Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 531

1.

Global Outcome Assessment Life-long after stroke in young adults initiative-the GOAL initiative: study protocol and rationale of a multicentre retrospective individual patient data meta-analysis.

Ekker M, Jacob M, van Dongen M, Aarnio K, Annamalai A, Arauz A, Arnold M, Barboza M, Bolognese M, Brouns R, Chuluun B, Chuluunbaatar E, Dagvajantsan B, Debette S, Don A, Enzinger C, Ekizoglu E, Fandler-Höfler S, Fazekas F, Fromm A, Gattringer T, Gulli G, Hoffmann M, Hora T, Jern C, Jood K, Kamouchi M, Kim YS, Kitazono T, Kittner S, Kleinig T, Klijn K, Korv J, Lee TH, Leys D, Maaijwee N, Martinez-Majander N, Marto JP, Mehndiratta M, Mifsud V, Montanaro V, Owolabi MO, Patel V, Phillips M, Piechowski-Iozwiak B, Pikula A, Ruiz-Sandoval JL, Sarnowski B, Schreuder F, Swartz R, Tan KS, Tanne D, Tatlisumak T, Thijs V, Tuladhar A, Viana-Baptista M, Vibo R, Wu T, Yesilot N, Waje-Andreassen U, Pezzini A, Putaala J, de Leeuw FE.

BMJ Open. 2019 Nov 14;9(11):e031144. doi: 10.1136/bmjopen-2019-031144.

PMID:
31727655
2.

Predictors of Lesion Cavitation After Recent Small Subcortical Stroke.

Gattringer T, Valdes Hernandez M, Heye A, Armitage PA, Makin S, Chappell F, Pinter D, Doubal F, Enzinger C, Fazekas F, Wardlaw JM.

Transl Stroke Res. 2019 Nov 8. doi: 10.1007/s12975-019-00741-8. [Epub ahead of print]

PMID:
31705427
3.

Morphological MRI phenotypes of multiple sclerosis differ in resting-state brain function.

Pinter D, Beckmann CF, Fazekas F, Khalil M, Pichler A, Gattringer T, Ropele S, Fuchs S, Enzinger C.

Sci Rep. 2019 Nov 7;9(1):16221. doi: 10.1038/s41598-019-52757-7.

4.

Global Burden of Small Vessel Disease-Related Brain Changes on MRI Predicts Cognitive and Functional Decline.

Jokinen H, Koikkalainen J, Laakso HM, Melkas S, Nieminen T, Brander A, Korvenoja A, Rueckert D, Barkhof F, Scheltens P, Schmidt R, Fazekas F, Madureira S, Verdelho A, Wallin A, Wahlund LO, Waldemar G, Chabriat H, Hennerici M, O'Brien J, Inzitari D, Lötjönen J, Pantoni L, Erkinjuntti T.

Stroke. 2019 Nov 8:STROKEAHA119026170. doi: 10.1161/STROKEAHA.119.026170. [Epub ahead of print]

PMID:
31699021
5.

Early renal dysfunction and fibroblast growth factor-23 in patients with small vessel disease-related stroke.

Fandler-Höfler S, Enzinger C, Kneihsl M, Pinter D, Eppinger S, Obermayer-Pietsch B, Goritschan A, Hafner-Giessauf H, Rosenkranz AR, Fazekas F, Gattringer T.

Sci Rep. 2019 Oct 28;9(1):15410. doi: 10.1038/s41598-019-51965-5.

6.

Quantification of cortical damage in multiple sclerosis using DTI remains a challenge.

Ropele S, Fazekas F.

Brain. 2019 Jul 1;142(7):1848-1850. doi: 10.1093/brain/awz160. No abstract available.

PMID:
31505544
7.

Comment on: External Validation of the PREMISE Score in the Athens Stroke Registry.

Gattringer T, Posekany A, Kiechl S, Fazekas F, Enzinger C.

J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104334. doi: 10.1016/j.jstrokecerebrovasdis.2019.104334. Epub 2019 Aug 20. No abstract available.

PMID:
31444044
8.

Vanishing midbrain mass lesion - A germinoma?

Purkart TU, Seifert-Held T, Haybäck J, Holl E, Asslaber M, Payer F, Fazekas F.

J Neurol Sci. 2019 Sep 15;404:40-43. doi: 10.1016/j.jns.2019.06.013. Epub 2019 Jun 13. No abstract available.

PMID:
31325666
9.

Blood Biomarkers of Heart Failure and Hypercoagulation to Identify Atrial Fibrillation-Related Stroke.

Kneihsl M, Gattringer T, Bisping E, Scherr D, Raggam R, Mangge H, Enzinger C, Fandler-Höfler S, Eppinger S, Hermetter C, Bucnik B, Poltrum B, Niederkorn K, Fazekas F.

Stroke. 2019 Aug;50(8):2223-2226. doi: 10.1161/STROKEAHA.119.025339. Epub 2019 Jun 20.

PMID:
31216968
10.

Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries.

Aguiar de Sousa D, von Martial R, Abilleira S, Gattringer T, Kobayashi A, Gallofré M, Fazekas F, Szikora I, Feigin V, Caso V, Fischer U.

Eur Stroke J. 2019 Mar;4(1):13-28. doi: 10.1177/2396987318786023. Epub 2018 Jul 20.

11.

Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.

Wilson D, Ambler G, Lee KJ, Lim JS, Shiozawa M, Koga M, Li L, Lovelock C, Chabriat H, Hennerici M, Wong YK, Mak HKF, Prats-Sánchez L, Martínez-Domeño A, Inamura S, Yoshifuji K, Arsava EM, Horstmann S, Purrucker J, Lam BYK, Wong A, Kim YD, Song TJ, Schrooten M, Lemmens R, Eppinger S, Gattringer T, Uysal E, Tanriverdi Z, Bornstein NM, Assayag EB, Hallevi H, Tanaka J, Hara H, Coutts SB, Hert L, Polymeris A, Seiffge DJ, Lyrer P, Algra A, Kappelle J, Al-Shahi Salman R, Jäger HR, Lip GYH, Mattle HP, Panos LD, Mas JL, Legrand L, Karayiannis C, Phan T, Gunkel S, Christ N, Abrigo J, Leung T, Chu W, Chappell F, Makin S, Hayden D, Williams DJ, Kooi ME, van Dam-Nolen DHK, Barbato C, Browning S, Wiegertjes K, Tuladhar AM, Maaijwee N, Guevarra C, Yatawara C, Mendyk AM, Delmaire C, Köhler S, van Oostenbrugge R, Zhou Y, Xu C, Hilal S, Gyanwali B, Chen C, Lou M, Staals J, Bordet R, Kandiah N, de Leeuw FE, Simister R, van der Lugt A, Kelly PJ, Wardlaw JM, Soo Y, Fluri F, Srikanth V, Calvet D, Jung S, Kwa VIH, Engelter ST, Peters N, Smith EE, Yakushiji Y, Orken DN, Fazekas F, Thijs V, Heo JH, Mok V, Veltkamp R, Ay H, Imaizumi T, Gomez-Anson B, Lau KK, Jouvent E, Rothwell PM, Toyoda K, Bae HJ, Marti-Fabregas J, Werring DJ; Microbleeds International Collaborative Network.

Lancet Neurol. 2019 Jul;18(7):653-665. doi: 10.1016/S1474-4422(19)30197-8. Epub 2019 May 23. Erratum in: Lancet Neurol. 2019 Sep;18(9):e8.

12.

Commentary on 'Spontaneous multiple cervical artery dissections after alemtuzumab'.

Pichler A, Fazekas F.

Mult Scler. 2019 May 9:1352458519845110. doi: 10.1177/1352458519845110. [Epub ahead of print] No abstract available.

PMID:
31070515
13.

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

Leurs CE, Twaalfhoven H, Lissenberg-Witte BI, van Pesch V, Dujmovic I, Drulovic J, Castellazzi M, Bellini T, Pugliatti M, Kuhle J, Villar LM, Alvarez-Cermeño JC, Alvarez-Lafuente R, Hegen H, Deisenhammer F, Walchhofer LM, Thouvenot E, Comabella M, Montalban X, Vécsei L, Rajda C, Galimberti D, Scarpini E, Altintas A, Rejdak K, Frederiksen JL, Pihl-Jensen G, Jensen P, Khalil M, Voortman MM, Fazekas F, Saiz A, La Puma D, Vercammen M, Vanopdenbosch L, Uitdehaag B, Killestein J, Bridel C, Teunissen C.

Mult Scler. 2019 May 8:1352458519845844. doi: 10.1177/1352458519845844. [Epub ahead of print]

PMID:
31066634
14.

Are morphologic features of recent small subcortical infarcts related to specific etiologic aspects?

Eppinger S, Gattringer T, Nachbaur L, Fandler S, Pirpamer L, Ropele S, Wardlaw J, Enzinger C, Fazekas F.

Ther Adv Neurol Disord. 2019 Apr 22;12:1756286419835716. doi: 10.1177/1756286419835716. eCollection 2019.

15.

Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations.

Thrippleton MJ, Backes WH, Sourbron S, Ingrisch M, van Osch MJP, Dichgans M, Fazekas F, Ropele S, Frayne R, van Oostenbrugge RJ, Smith EE, Wardlaw JM.

Alzheimers Dement. 2019 Jun;15(6):840-858. doi: 10.1016/j.jalz.2019.01.013. Epub 2019 Apr 25. Review.

16.

Postural hemodynamic parameters in older persons have a seasonal dependency : A pilot study.

Trozic I, Platzer D, Fazekas F, Bondarenko AI, Brix B, Rössler A, Goswami N.

Z Gerontol Geriatr. 2019 Mar 13. doi: 10.1007/s00391-019-01525-3. [Epub ahead of print]

PMID:
30868225
17.

White Matter Hyperintensities in Alzheimer's Disease: A Lesion Probability Mapping Study.

Damulina A, Pirpamer L, Seiler S, Benke T, Dal-Bianco P, Ransmayr G, Struhal W, Hofer E, Langkammer C, Duering M, Fazekas F, Schmidt R.

J Alzheimers Dis. 2019;68(2):789-796. doi: 10.3233/JAD-180982.

PMID:
30775995
18.

Magnetic resonance elastography of the human brain using a multiphase DENSE acquisition.

Strasser J, Haindl MT, Stollberger R, Fazekas F, Ropele S.

Magn Reson Med. 2019 Jun;81(6):3578-3587. doi: 10.1002/mrm.27672. Epub 2019 Jan 29.

19.

Quantitative Susceptibility Mapping to Assess Cerebral Vascular Compliance.

Birkl C, Langkammer C, Sati P, Enzinger C, Fazekas F, Ropele S.

AJNR Am J Neuroradiol. 2019 Mar;40(3):460-463. doi: 10.3174/ajnr.A5933. Epub 2019 Jan 24.

20.

Association between pathological and MRI findings in multiple sclerosis.

Filippi M, Brück W, Chard D, Fazekas F, Geurts JJG, Enzinger C, Hametner S, Kuhlmann T, Preziosa P, Rovira À, Schmierer K, Stadelmann C, Rocca MA; Attendees of the Correlation between Pathological and MRI findings in MS workshop.

Lancet Neurol. 2019 Feb;18(2):198-210. doi: 10.1016/S1474-4422(18)30451-4. Review.

PMID:
30663609
21.

Diagnostic accuracy of noncontrast CT imaging markers in cerebral venous thrombosis.

Buyck PJ, Zuurbier SM, Garcia-Esperon C, Barboza MA, Costa P, Escudero I, Renard D, Lemmens R, Hinteregger N, Fazekas F, Conde JJ, Giralt-Steinhauer E, Hiltunen S, Arauz A, Pezzini A, Montaner J, Putaala J, Weimar C, Churilov L, Gattringer T, Asadi H, Tatlisumak T, Coutinho JM, Demaerel P, Thijs V.

Neurology. 2019 Feb 19;92(8):e841-e851. doi: 10.1212/WNL.0000000000006959. Epub 2019 Jan 18.

PMID:
30659138
22.

Instead of tweaking the diagnostic criteria for MS in those with CIS, we should develop diagnostic criteria that distinguish MS from other conditions - Commentary.

Fazekas F.

Mult Scler. 2019 May;25(6):770-771. doi: 10.1177/1352458518820700. Epub 2019 Jan 11. No abstract available.

PMID:
30632449
23.

Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis.

Chatterjee M, Koel-Simmelink MJ, Verberk IM, Killestein J, Vrenken H, Enzinger C, Ropele S, Fazekas F, Khalil M, Teunissen CE.

Mult Scler J Exp Transl Clin. 2018 Dec 24;4(4):2055217318819535. doi: 10.1177/2055217318819535. eCollection 2018 Oct-Dec.

24.

Predicting Early Mortality of Acute Ischemic Stroke.

Gattringer T, Posekany A, Niederkorn K, Knoflach M, Poltrum B, Mutzenbach S, Haring HP, Ferrari J, Lang W, Willeit J, Kiechl S, Enzinger C, Fazekas F; Austrian Stroke Unit Registry Collaborators.

Stroke. 2019 Feb;50(2):349-356. doi: 10.1161/STROKEAHA.118.022863.

PMID:
30580732
25.

Nigral iron deposition in common tremor disorders.

Homayoon N, Pirpamer L, Franthal S, Katschnig-Winter P, Kögl M, Seiler S, Wenzel K, Hofer E, Deutschmann H, Fazekas F, Langkammer C, Ropele S, Schmidt R, Schwingenschuh P.

Mov Disord. 2019 Jan;34(1):129-132. doi: 10.1002/mds.27549. Epub 2018 Dec 10.

26.

Prevalence and short-term changes of cognitive dysfunction in young ischaemic stroke patients.

Pinter D, Enzinger C, Gattringer T, Eppinger S, Niederkorn K, Horner S, Fandler S, Kneihsl M, Krenn K, Bachmaier G, Fazekas F.

Eur J Neurol. 2019 May;26(5):727-732. doi: 10.1111/ene.13879. Epub 2019 Jan 9.

27.

The formation of a glial scar does not prohibit remyelination in an animal model of multiple sclerosis.

Haindl MT, Köck U, Zeitelhofer-Adzemovic M, Fazekas F, Hochmeister S.

Glia. 2019 Mar;67(3):467-481. doi: 10.1002/glia.23556. Epub 2018 Nov 28.

28.

Month-of-birth-effect in multiple sclerosis in Austria.

Walleczek NK, Frommlet F, Bsteh G, Eggers C, Rauschka H, Koppi S, Assar H, Ehling R, Birkl C, Salhofer-Polanyi S, Baumgartner A, Blechinger S, Buchinger D, Sellner J, Kraus J, Moser H, Mayr M, Guger M, Rathmaier S, Raber B, Liendl H, Hiller MS, Parigger S, Morgenstern G, Kempf I, Spiss HK, Meister B, Heine M, Cisar A, Bachler H, Khalil M, Fuchs S, Enzinger C, Fazekas F, Leutmezer F, Berger T, Kristoferitsch W, Aboulenein-Djamshidian F.

Mult Scler. 2018 Nov 22:1352458518810924. doi: 10.1177/1352458518810924. [Epub ahead of print]

PMID:
30463473
29.

Abnormal Blood Flow on Transcranial Duplex Sonography Predicts Poor Outcome After Stroke Thrombectomy.

Kneihsl M, Niederkorn K, Deutschmann H, Enzinger C, Poltrum B, Horner S, Thaler D, Kraner J, Fandler S, Colonna I, Fazekas F, Gattringer T.

Stroke. 2018 Nov;49(11):2780-2782. doi: 10.1161/STROKEAHA.118.023213.

PMID:
30355211
30.

Independence after stroke: Mind over matter.

Marsh EB, Fazekas F.

Neurology. 2018 Nov 13;91(20):903-904. doi: 10.1212/WNL.0000000000006494. Epub 2018 Oct 17. No abstract available.

PMID:
30333159
31.

The effect of disease modifying therapies on CD62L expression in multiple sclerosis.

Voortman MM, Greiner P, Moser D, Stradner MH, Graninger W, Moser A, Haditsch B, Enzinger C, Fuchs S, Fazekas F, Fessler J, Khalil M.

Mult Scler J Exp Transl Clin. 2018 Sep 20;4(3):2055217318800810. doi: 10.1177/2055217318800810. eCollection 2018 Jul-Sep.

32.

Systematic Review: Syndromes, Early Diagnosis, and Treatment in Autoimmune Encephalitis.

Hermetter C, Fazekas F, Hochmeister S.

Front Neurol. 2018 Sep 5;9:706. doi: 10.3389/fneur.2018.00706. eCollection 2018. Review.

33.

Neurofilaments as biomarkers in neurological disorders.

Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, Barro C, Kappos L, Comabella M, Fazekas F, Petzold A, Blennow K, Zetterberg H, Kuhle J.

Nat Rev Neurol. 2018 Oct;14(10):577-589. doi: 10.1038/s41582-018-0058-z. Review.

PMID:
30171200
34.

Cerebrovascular disorders.

Fazekas F, Gattringer T, Enzinger C.

Curr Opin Neurol. 2018 Aug;31(4):345-353. doi: 10.1097/WCO.0000000000000566. Review.

PMID:
29878907
35.

Case report of a woman with anti amphiphysin positive stiff person syndrome.

Manhalter N, Györfi O, Boros E, Bokor M, Fazekas F, Dénes Z, Fabó D, Kamondi A, Erőss L.

Ideggyogy Sz. 2017 May 30;70(5-6):213-216. doi: 10.18071/isz.70.0213.

PMID:
29870637
36.

Teaching NeuroImages: Convexal subarachnoid hemorrhage accompanied by transient global amnesia.

Beitzke M, Enzinger C, Fazekas F.

Neurology. 2018 May 22;90(21):e1933-e1934. doi: 10.1212/WNL.0000000000005567. No abstract available.

PMID:
29784726
37.

Dysphagia in supratentorial recent small subcortical infarcts results from bilateral pyramidal tract damage.

Fandler S, Gattringer T, Pinter D, Pirpamer L, Borsodi F, Eppinger S, Niederkorn K, Enzinger C, Fazekas F.

Int J Stroke. 2018 Oct;13(8):815-819. doi: 10.1177/1747493018778141. Epub 2018 May 18.

PMID:
29775168
38.

Repeated Endovascular Treatment of Early Recurrent Proximal Middle Cerebral Artery Occlusion: Case Report and Brief Review of the Literature.

Fandler S, Deutschmann H, Fazekas F, Gattringer T.

Front Neurol. 2018 May 3;9:289. doi: 10.3389/fneur.2018.00289. eCollection 2018.

39.

MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset.

Thomalla G, Simonsen CZ, Boutitie F, Andersen G, Berthezene Y, Cheng B, Cheripelli B, Cho TH, Fazekas F, Fiehler J, Ford I, Galinovic I, Gellissen S, Golsari A, Gregori J, Günther M, Guibernau J, Häusler KG, Hennerici M, Kemmling A, Marstrand J, Modrau B, Neeb L, Perez de la Ossa N, Puig J, Ringleb P, Roy P, Scheel E, Schonewille W, Serena J, Sunaert S, Villringer K, Wouters A, Thijs V, Ebinger M, Endres M, Fiebach JB, Lemmens R, Muir KW, Nighoghossian N, Pedraza S, Gerloff C; WAKE-UP Investigators.

N Engl J Med. 2018 Aug 16;379(7):611-622. doi: 10.1056/NEJMoa1804355. Epub 2018 May 16.

40.

Longitudinal MRI dynamics of recent small subcortical infarcts and possible predictors.

Pinter D, Gattringer T, Enzinger C, Seifert-Held T, Kneihsl M, Fandler S, Pichler A, Barro C, Eppinger S, Pirpamer L, Bachmaier G, Ropele S, Wardlaw JM, Kuhle J, Khalil M, Fazekas F.

J Cereb Blood Flow Metab. 2019 Sep;39(9):1669-1677. doi: 10.1177/0271678X18775215. Epub 2018 May 8.

PMID:
29737904
41.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N; Jacqueline Palace on behalf of the MAGNIMS study group.

Nat Rev Neurol. 2018 Mar 20;14(4):213. doi: 10.1038/nrneurol.2018.39.

PMID:
29582852
42.

Stroke Referrals from Nursing Homes: High Rate of Mimics and Late Presentation.

Kneihsl M, Enzinger C, Niederkorn K, Wünsch G, Müller L, Culea V, Lueger A, Fazekas F, Gattringer T.

Cerebrovasc Dis. 2018;45(3-4):109-114. doi: 10.1159/000487813. Epub 2018 Mar 14.

PMID:
29539602
43.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N, Palace J; MAGNIMS study group.

Nat Rev Neurol. 2018 Apr;14(4):199-213. doi: 10.1038/nrneurol.2018.14. Epub 2018 Mar 9. Review. Erratum in: Nat Rev Neurol. 2018 Mar 20;14 (4):213.

PMID:
29521337
44.

Management of multiple sclerosis patients in central European countries: current needs and potential solutions.

Berger T, Adamczyk-Sowa M, Csépány T, Fazekas F, Hojs Fabjan T, Horáková D, Illes Z, Klimová E, Leutmezer F, Rejdak K, Rozsa C, Šega Jazbec S, Szilasiová J, Turčáni P, Vachová M, Vécsei L, Havrdová E.

Ther Adv Neurol Disord. 2018 Feb 22;11:1756286418759189. doi: 10.1177/1756286418759189. eCollection 2018. Review.

45.

Predictors of gait speed and its change over three years in community-dwelling older people.

Pinter D, Ritchie SJ, Gattringer T, Bastin ME, Hernández MDCV, Corley J, Maniega SM, Pattie A, Dickie DA, Gow AJ, Starr JM, Deary IJ, Enzinger C, Fazekas F, Wardlaw J.

Aging (Albany NY). 2018 Jan 20;10(1):144-153. doi: 10.18632/aging.101365.

46.

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis.

Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F.

Mult Scler. 2018 Feb;24(2):96-120. doi: 10.1177/1352458517751049. Epub 2018 Jan 20.

PMID:
29353550
47.

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F.

Eur J Neurol. 2018 Feb;25(2):215-237. doi: 10.1111/ene.13536. Epub 2018 Jan 19. Erratum in: Eur J Neurol. 2018 Mar;25(3):605.

PMID:
29352526
48.

Increased middle cerebral artery mean blood flow velocity index after stroke thrombectomy indicates increased risk for intracranial hemorrhage.

Kneihsl M, Niederkorn K, Deutschmann H, Enzinger C, Poltrum B, Fischer R, Thaler D, Hermetter C, Wünsch G, Fazekas F, Gattringer T.

J Neurointerv Surg. 2018 Sep;10(9):882-887. doi: 10.1136/neurintsurg-2017-013617. Epub 2017 Dec 28.

PMID:
29288194
49.

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA.

Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. Review.

PMID:
29275977
50.

Acute diffusion-weighted imaging lesions in cerebral amyloid angiopathy-related convexal subarachnoid hemorrhage.

Beitzke M, Enzinger C, Pichler A, Wünsch G, Fazekas F.

J Cereb Blood Flow Metab. 2018 Feb;38(2):225-229. doi: 10.1177/0271678X17744736. Epub 2017 Nov 23.

Supplemental Content

Loading ...
Support Center